A method for quantification of nucleotides and nucleotide analogues in thymidine kinase assays using lanthanum phosphate coprecipitation

Analytical Biochemistry

Volumn 369, Issue 1, 2007, Pages 80-86

  Gammon, S T ^a,b   Bernstein, M ^a,b   Schuster, D P ^a,b   Piwnica Worms, D ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lanthanum phosphate; Nucleoside; Nucleotide; Thymidine kinase

Indexed keywords

CELL CULTURE; CHLORINE COMPOUNDS; COPRECIPITATION; ENZYMES; NUCLEOTIDES;

LANTHANUM CHLORIDES; LANTHANUM PHOSPHATE; NUCLEOSIDE; NUCLEOSIDE ANALOGUES; NUCLEOSIDE MONOPHOSPHATES; NUCLEOTIDE ANALOGUES; PYRIMIDINE NUCLEOSIDES; THYMIDINE KINASE;

LANTHANUM COMPOUNDS;

LANTHANUM; LANTHANUM PHOSPHATE; NUCLEOTIDE; NUCLEOTIDE DERIVATIVE; PENCICLOVIR; PURINE NUCLEOSIDE; PYRIMIDINE NUCLEOSIDE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PH; POLYMERASE CHAIN REACTION; PRECIPITATION; PRIORITY JOURNAL;

EID: 34548169800     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.06.018     Document Type: Article

References (34)

1. Pinedo H.M., and Peters G.F. Fluorouracil: biochemistry and pharmacology. J. Clin. Oncol. 6 (1988) 1653-1664
2. Johansson M., van Rompay A.R., Degreve B., Balzarini J., and Karlsson A. Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster. J. Biol. Chem. 274 (1999) 23814-23819
3. Vogt J., Perozzo R., Pautsch A., Prota A., Schelling P., Pilger B., Folkers G., Scapozza L., and Schulz G.E. Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography. Proteins 41 (2000) 545-553
4. Balzarini J., Liekens S., Solaroli N., El Omari K., Stammers D.K., and Karlsson A. Engineering of a single conserved amino acid residue of herpes simplex virus type 1 thymidine kinase allows a predominant shift from pyrimidine to purine nucleoside phosphorylation. J. Biol. Chem. 281 (2006) 19273-19279
5. Black M., Newcomb T., Wilson H., and Loeb M. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc. Natl. Acad. Sci. USA 93 (1996) 3525-3529
6. Gupta R., and Wald A. Genital herpes: antiviral therapy for symptom relief and prevention of transmission. Expert Opin. Pharmacother. 7 (2006) 665-675
7. Sterman D.H., Recio A., Vachani A., Sun J., Cheung L., DeLong P., Amin K.M., Litzky L.A., Wilson J.M., Kaiser L.R., and Albelda S.M. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase/ganciclovir suicide gene therapy. Clin. Cancer Res. 11 (2005) 7444-7453
8. Hinata N., Shirakawa T., Terao S., Goda K., Tanaka K., Yamada Y., Hara I., Kamidono S., Fujisawa M., and Gotoh A. Progress report on phase I/II clinical trial of Ad-OC-TK plus VAL therapy for metastatic or locally recurrent prostate cancer: initial experience at Kobe University. Intl. J. Urol. 13 (2006) 834-837
9. Ponomarev V., Doubrovin M., Lyddane C., Beresten T., Balatoni J., Bornman W., Finn R., Akhurst T., Larson S., Blasberg R., Sadelain M., and Tjuvajev J. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia 3 (2001) 480-488
10. Richard J.C., Zhou Z., Chen D.L., Mintun M.A., Piwnica-Worms D., Factor P., Ponde D.E., and Schuster D.P. Quantitation of pulmonary transgene expression with PET imaging. J. Nuclear Med. 45 (2004) 644-654
11. Le L.Q., Kabarowski J.H.S., Wong S., Nguyen K., Gambhir S.S., and Witte O.N. Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene. Cancer Cell 1 (2002) 381-391
12. Gross S., and Piwnica-Worms D. Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7 (2005) 5-15
13. Luker G., Sharma V., Pica C., Dahlheimer J., Li W., Ochesky J., Ryan C., Piwnica-Worms H., and Piwnica-Worms D. Noninvasive imaging of protein-protein interactions in living animals. Proc. Natl. Acad. Sci. USA 99 (2002) 6961-6966
14. Solaroli N., Johansson M., Balzarini J., and Karlsson A. Substrate specificity of three viral thymidine kinases (TK): vaccinia virus TK, feline herpesvirus TK, and canine herpesvirus TK. Nucleosides Nucleotides Nucleic Acids 25 (2006) 1189-1192
15. Solaroli N., Johansson M., Balzarini J., and Karlsson A. Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants. Gene. Ther. 14 (2007) 86-92
16. 18F]fluoroethyl-β-(-d-arabinofuranosyl uracil. Nuclear Med. Biol. 32 (2005) 811-819
17. Willmon C.L., Krabbenhoft E., and Black M.E. A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing. Gene Ther. 13 (2006) 1309-1312
18. Litteria M., and Popoff C.G. An efficient washing procedure for thymidine kinase assay. Neurochem. Res. 6 (1981) 931-934
19. Munch-Petersen B., Cloos L., Tyrsted G., and Eriksson S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J. Biol. Chem. 266 (1991) 9032-9038
20. Gerber S., and Folkers G. A new method for quantitative determination of tritium-labeled nucleoside kinase products adsorbed on DEAE-cellulose. Biochem. Biophys. Res. Commun. 225 (1996) 263-267
21. el Kouni M.H., and Cha S. A simple radioisotopic assay for nucleoside kinases employing alumina for separation of nucleosides and nucleotides. Anal. Biochem. 111 (1981) 67-71
22. Wolcott R., and Colacino J. Detection of thymidine kinase activity using an assay based on precipitation of nucleoside monophosphates with lanthanum chloride. Anal. Biochem. 178 (1989) 38-40
23. Kokoris M.S., and Black M.E. Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity. Protein Sci. 11 (2002) 2267-2272
24. Richard J.C., Zhou Z., Ponde D.E., Dence C.S., Factor P., Reynolds P.N., Luker G.D., Sharma V., Ferkol T., Piwnica-Worms D., and Schuster D.P. Imaging pulmonary gene expression with positron emission tomography. Am. J. Respir. Crit. Care Med. 167 (2003) 1257-1263
25. Tajmir-Riahi H.A., Ahmad R., and Naoui M. Interaction of calf-thymus DNA with trivalent lanthanum, europium, and terbium ions: metal ion binding, DNA condensation, and structural features. J. Biomol. Struct. Dynam. 10 (1993) 865-877
26. Rogstad K.N., Jang Y.H., Sowers L.C., and Goddard III W.A. First principles calculations of the pKa values and tautomers of isoguanine and xanthine. Chem. Res. Toxicol. 16 (2003) 1455-1462
27. Firsching F.H., and Brune S.N. Solubility products of the trivalent rare-earth phosphates. J. Chem. Eng. Data 36 (1991) 93-95
28. Oivanen M., Schnell R., Pfleiderer W., and Lonnberg H. Interconversion and hydrolysis of monomethyl and monoisopropyl esters of adenosine 2′-monophosphates and 3′-monophosphates: kinetics and mechanisms. J. Org. Chem. 56 (1991) 3623-3628
29. Furlong N.B. A rapid assay for nucleotide kinases using C14- or H3-labeled nucleotides. Anal. Biochem. 5 (1963) 515-522
30. Breitman T.R. The feedback inhibition of thymidine kinase. Biochim. Biophys. Acta 67 (1963) 153-155
31. Wurth C., Thomas R.M., Folkers G., and Scapozza L. Folding and self-assembly of herpes simplex virus type 1 thymidine kinase. J. Mol. Biol. 313 (2001) 657-670
32. Balzarini J., Liekens S., Esnouf R., and De Clercq E. The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase. Biochemistry 41 (2002) 6517-6524
33. Kokoris M., Sabo P., Adman E., and Black M. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant. Gene Ther. 6 (1999) 1415-1426
34. Hinds T.A., Compadre C., Hurlburt B.K., and Drake R.R. Conservative mutations of glutamine-125 in herpes simplex virus type 1 thymidine kinase result in a ganciclovir kinase with minimal deoxypyrimidine kinase activities. Biochemistry 19 (2000) 4105-4111